XSHE
003022
Market cap3.68bUSD
Oct 09, Last price
18.35CNY
1D
-0.60%
1Q
-11.74%
IPO
31.45%
Name
Levima Advanced Materials Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Beijing, China, Levima Advanced Materials Corporation specializes in the innovation, production, and global distribution of sophisticated materials and specialized chemical compounds. Its comprehensive product range features premium EVA copolymers, custom-developed polypropylene materials, ethylene oxide and its various derivatives, in addition to polycarboxylate water reducers and nonionic surfactants. These offerings are widely utilized across numerous industries, including plastics manufacturing, solar energy (photovoltaic applications), cabling, household consumer goods, textiles, construction and infrastructure (encompassing roads and bridges), leather processing, and paints/coatings. The company maintains an expansive international sales network, distributing its products throughout China, the United States, European countries, the African continent, and various Southeast Asian nations. Furthermore, Levima Advanced Materials provides extensive customer support, which includes pre-sales consultation, technical assistance, logistics coordination, and thorough post-sale services.
Key people
Huilong Han
Senior Vice President · since 2021
Jun Li
Senior Vice President · since 2021
Fang Li
Senior Vice President · since 2018
Yaping Xie
Senior Vice President · since 2021
Wenquan Cai
Finance Director, Senior Vice President, Secretary of the Board, Director · since 2021
Jing Chen
Director · since 2023
Peng Li
Director · since 2020
Haili Zhao
Senior Vice President, Director · since 2023
Yueming Zheng
Chairman of the Board, President · since 2018
Hua Han
Independent Director · since 2024
Na Sun
Independent Director · since 2024
Guoliang Wang
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||